fluoxetine has been researched along with ursodoxicoltaurine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Cai, W; Khaoustov, VI; Le, W; Pan, T; Xie, Q; Yoffe, B | 1 |
Gao, MH; Gong, Y; Hu, WF; Huang, C; Lu, X; Wang, P; Wu, Y; Yang, RR; Zhang, JL | 1 |
Chen, Z; Cheng, L; Huang, C | 1 |
4 other study(ies) available for fluoxetine and ursodoxicoltaurine
Article | Year |
---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interferon-alpha-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antiviral Agents; Cell Cycle; Depressive Disorder, Major; Desipramine; Down-Regulation; Fluoxetine; Gene Expression; Hepatoblastoma; Humans; Interferon-alpha; Jurkat Cells; Liver Neoplasms; Oligonucleotide Array Sequence Analysis; Receptor, Serotonin, 5-HT1A; Receptors, Glucocorticoid; Taurochenodeoxycholic Acid | 2005 |
Tauroursodeoxycholic acid produces antidepressant-like effects in a chronic unpredictable stress model of depression via attenuation of neuroinflammation, oxido-nitrosative stress, and endoplasmic reticulum stress.
Topics: Animals; Antidepressive Agents; Depression; Disease Models, Animal; Endoplasmic Reticulum Stress; Fluoxetine; Hindlimb Suspension; Hippocampus; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitrosative Stress; Oxidative Stress; Prefrontal Cortex; Stress, Psychological; Swimming; Taurochenodeoxycholic Acid | 2018 |
Tauroursodeoxycholic Acid Ameliorates Lipopolysaccharide-Induced Depression Like Behavior in Mice via the Inhibition of Neuroinflammation and Oxido-Nitrosative Stress.
Topics: Animals; Antidepressive Agents; Cytokines; Depression; Disease Models, Animal; Fluoxetine; Hippocampus; Inflammation; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Nitrosative Stress; Oxidative Stress; Prefrontal Cortex; Taurochenodeoxycholic Acid; Tumor Necrosis Factor-alpha | 2019 |